Answers are grounded in this paper and cite their sources.
Piperacillin-tazobactam was administered as a single dose (4.5 g intravenous) to five patients with stabilized external pancreatic fistula. The penetration into pancreatic juice was prompt, and inhibitory concentrations were achieved and maintained for different periods (0.5 to 6 h) according to bacterial susceptibility and patients' characteristics. Piperacillin and tazobactam showed superimposable pharmacokinetics in both serum and pancreatic juice.
No takes yet. Share an insight, caveat, or question.
Minelli et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: